Primary Care/Hospitalist
RSSArticles
-
Advisory panel votes against Qnexa
-
Weight loss without cardiac side effects
A new weight-loss medication may soon be available in the United States. Arena pharmaceuticals has filed a new drug application with the FDA for lorcaserin, a selective serotonin 2C-receptor agonist, and will likely get a formal review this fall. -
Emergency Medicine Reports - Full September 13, 2010 Issue in Streaming Audio/Downloadable MP3 Format
-
Emergency Medicine Reports - Full September 13 2010 Issue in PDF
-
Pharmacology Watch - Full September 2010 Issue in PDF
-
New REMS for quinine
-
No increase in seizures with DTaP vaccine
-
Breast cancer indication for bevacizumab
-
Mixed vote on rosiglitazone
-
Clinical Briefs by Louis Kuritzky, MD
Of late, there has been a renaissance of interest in identification and management of hypogonadism in older men.